Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Portfolio yield
Data as at : 30/06/2026
| % |
|---|
| 0.6 |
Please note that the above fields are displayed for companies that have reported this data to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 31/05/2026
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 9.5 |
| Roche Holding AG Ordinary Shares new | 6.3 |
| UnitedHealth Group Inc | 6.1 |
| AstraZeneca PLC | 5.5 |
| Thermo Fisher Scientific Inc | 4.9 |
| Teva Pharmaceutical Industries Ltd ADR | 4.8 |
| CVS Health Corp | 4.4 |
| The Cigna Group | 3.7 |
| Novo Nordisk AS Class B | 3.6 |
| Merck KGaA | 3.4 |
Geographic breakdown
Data as at : 30/06/2026
| Country | % of total assets |
|---|---|
| USA | 59.0 |
| UK | 6.0 |
| Germany | 5.0 |
| Switzerland | 5.0 |
| Israel | 4.0 |
| Canada | 3.0 |
| India | 3.0 |
| Japan | 3.0 |
| Netherlands | 3.0 |
| Bermuda | 2.0 |
| Ireland | 2.0 |
| Denmark | 1.0 |
| France | 1.0 |
| Sweden | 1.0 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 31/05/2026
| Industry | % of total assets |
|---|---|
| Healthcare | 108.4 |
| Cash Equivalents | -8.4 |
Scroll
Asset breakdown
Data as at : 31/05/2026
| Asset | % of total assets |
|---|---|
| Stock | 108.4 |
| Cash/Cash equivalents | -8.4 |
Detailed asset breakdown
Data as at : 31/05/2026
| Asset | % of total assets |
|---|---|
| North America - stock | 62.1 |
| Europe - Large-cap stock | 13.3 |
| UK - Large core/growth stock | 7.5 |
| Europe - Small-cap stock | 5.4 |
| Asia (excl Japan) - stock | 5.1 |
| Emerging markets - stock | 4.8 |
| Japan - stock | 3.6 |
| Europe - Mid-cap stock | 2.9 |
| Other - stock | 2.2 |
| UK - Mid core/growth stock | 1.6 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
